Stelara 90 MG/ML syringeml
Ended Awarded Last action
- Contract number
- SPE2DR26FCRN2
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,584
Award facts
- Contract value 100% obligated
- $16,584.13 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $16,584.13 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Stelara 90 mg/mL syringes. The award was issued on December 10, 2025, with an ultimate completion date of January 2, 2026, and carries no set-aside designation. This delivery order was issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) designated SPE2DR, which was established under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative on November 13, 2025, with a $499.999 billion ceiling and completion date of December 31, 2036.
The PPV-G GEN V represents a $30.3 billion acquisition strategy designed to enable the Defense Logistics Agency to issue delivery orders for comprehensive pharmaceutical products and medical consumables to support Department of Defense military healthcare operations globally. DMS Pharmaceutical Group's established performance as a critical pharmaceutical supplier within the federal supply chain, demonstrated through numerous prior delivery orders spanning oncology treatments, immunosuppressants, biologics, vaccines, and specialty pharmaceuticals, positions the company to fulfill the diverse medical supply requirements of military healthcare facilities. No subcontractors have been identified in this award documentation.
Quick answers
Who was awarded contract SPE2DR26FCRN2?
SPE2DR26FCRN2 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 10, 2025.
How much is contract SPE2DR26FCRN2 worth?
The government has obligated $16,584 on SPE2DR26FCRN2.
Is contract SPE2DR26FCRN2 an order under another contract?
Yes. SPE2DR26FCRN2 is a delivery order under SPE2DR25D9168, an indefinite delivery contract.
Was contract SPE2DR26FCRN2 competed?
The extent of competition for SPE2DR26FCRN2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award